Revance Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2015 - 2019
Operating Revenue	5.85	8.05	5.4	6.1	3.89	Upgrade
Revenue	5.85	8.05	5.4	6.1	3.89	Upgrade
Revenue Growth (YoY)	-27.32%	49.03%	-11.42%	56.69%	36.57%	Upgrade
Cost of Revenue	1.77	2.82	2.64	1.72	0.81	Upgrade
Gross Profit	4.08	5.24	2.77	4.38	3.08	Upgrade
Selling, General & Admin	49.08	44.83	50.77	39.86	11.67	Upgrade
Research & Development	4.85	5.75	4.04	5.1	2.09	Upgrade
Operating Expenses	58.49	55.32	59.96	49.18	15.03	Upgrade
Operating Income	-54.41	-50.08	-57.19	-44.8	-11.94	Upgrade
Interest Expense	-3.54	-2.85	-1.83	-1.47	-0.14	Upgrade
Interest & Investment Income	1.37	1.61	0.04	0.01	0.03	Upgrade
Currency Exchange Gain (Loss)	-1.18	1.36	2.72	5.2	-0.06	Upgrade
Other Non Operating Income (Expenses)	-1.66	3.51	0.54	-2.68	0.58	Upgrade
EBT Excluding Unusual Items	-59.42	-46.45	-55.73	-43.75	-11.54	Upgrade
Gain (Loss) on Sale of Investments	-15.31	-	-	-8.11	-	Upgrade
Asset Writedown	-	-	-	-	-2	Upgrade
Other Unusual Items	-	-	-	-	0.1	Upgrade
Pretax Income	-74.72	-46.45	-55.73	-51.86	-13.45	Upgrade
Income Tax Expense	0.1	-0.2	-	-	-	Upgrade
Net Income	-74.82	-46.25	-55.73	-51.86	-13.45	Upgrade
Net Income to Common	-74.82	-46.25	-55.73	-51.86	-13.45	Upgrade
Shares Outstanding (Basic)	497	487	487	464	366	Upgrade
Shares Outstanding (Diluted)	497	487	487	464	366	Upgrade
Shares Change (YoY)	1.93%	0.18%	4.78%	26.80%	169.49%	Upgrade
EPS (Basic)	-0.15	-0.09	-0.11	-0.11	-0.04	Upgrade
EPS (Diluted)	-0.15	-0.09	-0.12	-0.11	-0.04	Upgrade
Free Cash Flow	-70.32	-55.42	-86.76	-112.99	-25.66	Upgrade
Free Cash Flow Per Share	-0.14	-0.11	-0.18	-0.24	-0.07	Upgrade
Gross Margin	69.76%	65.02%	51.16%	71.73%	79.18%	Upgrade
Operating Margin	-929.39%	-621.75%	-1058.22%	-734.29%	-306.70%	Upgrade
Profit Margin	-1278.04%	-574.19%	-1031.13%	-850.01%	-345.34%	Upgrade
Free Cash Flow Margin	-1201.22%	-688.11%	-1605.40%	-1851.97%	-659.13%	Upgrade
EBITDA	-50.46	-45.77	-52.48	-41.02	-10.68	Upgrade
EBITDA Margin	-	-	-	-	-274.22%	Upgrade
D&A For EBITDA	3.95	4.31	4.71	3.78	1.26	Upgrade
EBIT	-54.41	-50.08	-57.19	-44.8	-11.94	Upgrade

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.